Cargando…
Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer
Metastatic colorectal cancer (mCRC) remains challenging because of the emergence of resistance mechanisms to anti-epidermal growth factor receptor (EGFR) therapeutics, so more effective strategies to improve the patients’ outcome are needed. During the last decade, the application of a multi-omics a...
Autores principales: | Porru, Manuela, Zizza, Pasquale, Panera, Nadia, Alisi, Anna, Biroccio, Annamaria, Leonetti, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408740/ https://www.ncbi.nlm.nih.gov/pubmed/32650388 http://dx.doi.org/10.3390/cancers12071830 |
Ejemplares similares
-
Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
por: Porru, Manuela, et al.
Publicado: (2018) -
Patient-derived xenografts: a relevant preclinical model for drug development
por: Pompili, Luca, et al.
Publicado: (2016) -
Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities
por: Rizzo, Angela, et al.
Publicado: (2014) -
Erratum: Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities
por: Rizzo, Angela, et al.
Publicado: (2015) -
A basal level of DNA damage and telomere deprotection increases the sensitivity of cancer cells to G-quadruplex interactive compounds
por: Salvati, Erica, et al.
Publicado: (2015)